Prof Subhabrata Moitra, PhD, FRSPH is an expert in Pulmonology at Ahmedabad University (India). As of November 2026, ScienceLeadR ranks Subhabrata Moitra in the top 1% of experts in India for Lung Diseases, Obstructive. Subhabrata Moitra has authored 89 publications, the most recent in 2026, and is an investigator in 1 clinical trial, 1 of them ongoing. SLR score: 348 (community average: 125). How the SLR is computed.

LeadR Profile

Profile validated by the expert
Prof Subhabrata Moitra, PhD, FRSPH Ahmedabad University India
348 ScienceLeadR Reputation 348
Network Map

Pulmonology

Subspecialties: Immunology - Public Health

Full career – Last 3 years

Main Topics

Publications and Clinical Studies

Publications – Clinical Studies

Profile data updated on

Organizations

Career arc: 2013 - 2026
Source: PubMed

Ahmedabad University - Assistant Professor

2024 - 2026

Publications Synthesis

Sources: PubMed, OpenAlex

Number : 89

Citations

Citations: 525 1st author: 37 Last author: 29 Unique author: 2


Best Journals

Breakdown by type

Click a legend label to hide or show it in the chart.

Latest Publications

5 most recent indexed articles

Source: Pubmed

Title Journal Year Citations
Benralizumab Inhibits Upper Airway Expression of Thymic Stromal Lymphopoietin in Severe Asthma.
PMID 42963590 — hypersensitivity, asthma
Clin Exp Allergy20260
Toxic skies of war.
PMID 42208953
Lancet Respir Med Top journal20260
Association Between Asthma and Chronic Bone Diseases: A Cross-Sectional Analysis From the Longitudinal Ageing Study in India (LASI) Data.
PMID 41956479 — cross-sectional studies, hypersensitivity, bone diseases, asthma
Clin Exp Allergy20260
Tezepelumab Reduces Alarmin Cytokine Levels in Upper Airway Epithelial Cells in Patients With Severe Asthma.
PMID 41896176 — cytokines, cells, epithelial cells, hypersensitivity, alarmins, asthma
Clin Exp Allergy20260
Asthma and higher social isolation among middle-aged adults: A structural equation analysis of nationwide data in India.
PMID 41687870 — hypersensitivity, social isolation, aged, asthma
J Allergy Clin Immunol Pract20261

Clinical Studies 1

Sources: ClinicalTrials, EU CTIS

Synthesis

By phase:

Phase 4 1

By status:

Recruiting 1

By type:

Interventional 1

By Monocentric/Multicentric:

monocentric 0
multicentric2to4 1
multicentric5to9 0
multicentricup10 0

Main Topics

Ongoing Clinical Trials

Ongoing trial started since 2021, where this expert is an investigator

Source: ClinicalTrials

Study Phase Status Start
Tezepelumab in the Treatment of Emergency Room Asthma in Adults (TERAA)
NCT06705764 — emergencies, therapeutics, asthma, steroids, emergency service, hospital
Phase 4Recruiting2026

LeadR Networks

Main global connection map